$PVSP (“Pervasip” or the “Company”), a developer
$PVSP (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its 3rd Quarter ended August 31, 2022.
“Q3 2022 shows material signs of improvement over Q2 2022 reflecting our ongoing operational focus. As stated before, we continue to pursue our strategic goals even during these difficult market conditions as evidenced by our recent agreements on terms for the acquisition of the Emerald City Cultivation and Dabco brands. Our operational and financial focus on rationalizing our business, shedding underperforming assets, and increasing production yields by our independent cultivators continues to proceed and have allowed us to continue with additional market share capture. Investing in Cannabis is not for the faint of heart and we believe we are building a solid foundation for years to come which takes time, patience, and relentless focus on fundamentals. In an industry that does not have access to traditional financing, our options are limited and expensive,” said German Burtscher, Pervasip’s CEO. “We slowed the rollout of our new concentrate brands which we licensed for Q3 deployment and instead focused on an outright acquisition as the opportunity became available. That resulted in not meeting the forecasted revenue from the new product lineup for Q3. We are also pursuing a conservative approach to working within the complicated tax environment our industry is confronted with. Ongoing work in support of the audit process and a recent court ruling that impacts the cannabis industry caused us to change our estimates for tax liability dating back to prior periods 2017 – 2020, which we booked in Q3.”
The Company continues to focus on moving available bulk inventory into higher margin brands with a focus on margin capture and is seeing promising early results.
Third Quarter 2022 Financial Results
Q3 2022 versus Q2 2022
Q3 2022 operating results improved over Q2 2022, tracking with ongoing efforts to shift bulk sales to higher margin brands combined with relative COGs reductions, even when adjusted for inventory.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...
Continue Reading
Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....
Continue Reading
Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...
Continue Reading
Legal Eagles Soar in the Sunshine State Right out of the gate, it looks like Greenberg Traurig's West Palm Beach office is getting all the spotlight. Twenty-one of their legal hotshots have clinched spots on Palm Beach Illustrated's 2026 'Top Lawyers' list. For those keeping score, that's a hefty nod in this competitive market. A Closer Look at the Selection Process Now,...
Continue Reading
Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...
Continue Reading
Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...
Continue Reading
Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...
Continue Reading
Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...
Continue Reading
Alright, let's dive into this world of shiny new gadgets that LG Electronics has trotted out at the IFA 2026. As European homes get cozier, folks aren't just after any appliance—they're seeking ones that blend smarts, efficiency, and style. So, LG's rolling out seven of their latest and supposedly greatest home appliances, hoping they'll hit the mark with the modern...
Continue Reading
Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Leadership Changes at VersaBank VersaBank (TSX: VBNK) (NASDAQ: VBNK), a leader in North American digital banking and cybersecurity solutions, has recently announced a significant transition within its executive team. This strategic move involves transferring key team members responsible for the success of the Receivable Purchase Program (RPP) to the United...
Continue Reading
FuelPositive Completes Private Placement Successfully FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) has successfully completed a significant non-brokered private placement, raising a total of $490,878. This was achieved by issuing 8,925,055 units at a price of $0.055 per unit. Each unit consists of one common share along with a share purchase warrant, which can be...
Continue Reading
NYSE Group's Latest Short Interest Overview The latest short interest data offers valuable insights into trading behaviors and market sentiment related to various securities. A recent report from NYSE, which was finalized with figures as of the mid-September settlement date, highlights shifts in market dynamics. For investors, grasping these trends is crucial for...
Continue Reading
Bank of America’s Insights on Metals Market for 2025 Bank of America (BofA) analysts are painting a picture of a metals and minerals market that could experience significant fluctuations as we approach 2025. Various factors are expected to play a crucial role, including shifting trade policies, supply challenges, and evolving demand patterns. Price Forecasts for...
Continue Reading
Strategic Review Urged by Activist Investor By Svea Herbst-Bayliss Activist investor Barington Capital Group is advocating that TriMas initiate a comprehensive strategic review, considering various options such as a potential sale of the entire company. The firm argues in a recent letter that engaging a financial adviser should take precedence over the search for a new...
Continue Reading